Yang Pan Lab @ UIC
University of Illinois Chicago College of Medicine
Hello from Dr. Yang Pan’s Laboratory of Omics and Precision Health at the University of Illinois Chicago!
Our lab focuses on understanding the molecular mechanisms underlying aging-related diseases through multi-omics and computational precision health approaches. We integrate genomics, transcriptomics, proteomics, metabolomics, and imaging data to identify biomarkers, uncover causal pathways, and develop predictive models for precision interventions.
Key research areas:
1. Aging Nuclear and Mitochondrial Genomics: Investigating somatic mutations, including clonal hematopoiesis (CHIP) and mitochondrial genome alterations, to understand their roles in chronic kidney disease, cognitive impairment, and other aging-related conditions.
2. Multi-Omics Integration: Developing computational and machine learning frameworks to combine genomics, epigenomics, transcriptomics, proteomics, metabolomics, and emerging modalities such as single-cell and spatial omics for disease risk prediction.
3. Computational Precision Health: Creating bioinformatics methods to integrate complex omics datasets, enabling predictive modeling, causal inference, and identification of novel therapeutic targets.
Our mission is to leverage multi-omics data and advanced computational approaches to improve disease risk prediction, stratify patients for precision interventions, and ultimately inform strategies to delay or prevent age-related chronic diseases.
news
| Oct 07, 2025 | Welcome Dr. Zhijie Huang! 🎉 Our very first postdoctoral fellow in the lab. Zhijie has been awarded a fellowship from the UIC COM AI.Health4All Center! |
|---|---|
| Aug 11, 2025 | Dr. Yang Pan has officially received his R00 award to support research on mitochondria and brain aging! |
| Jul 20, 2025 | The Pan lab started at the University of Illinois Chicago Department of Medicine. Decoding aging and health, one dataset (multiple omics) at a time! |
selected publications
2025
- Epigenetic age acceleration and midlife cognition: joint evidence from observational study and Mendelian randomizationnpj Aging, 2025
2024
- Clonal hematopoiesis of indeterminate potential is associated with reduced risk of cognitive impairment in patients with chronic kidney diseaseAlzheimer’s & Dementia, 2024
- Association of Clonal Hematopoiesis of Indeterminate Potential with Cardiovascular Events in Patients with CKDJournal of the American Society of Nephrology, 2024
- Clonal Hematopoiesis of Indeterminate Potential and Progression of CKDJournal of the American Society of Nephrology, 2024
2023
- IRIS: Discovery of cancer immunotherapy targets arising from pre-mRNA alternative splicingProceedings of the National Academy of Sciences, 2023
2020
- Pathway-guided analysis identifies Myc-dependent alternative pre-mRNA splicing in aggressive prostate cancersProceedings of the National Academy of Sciences, 2020